← Leaderboards
Thomas Meek
Texas A&M Agrilife Research
$2,544,314
Attributed
$5,980,817
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2017–23$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$5,980,817 · 3
By mechanism
R01$5,154,754 · 1
R21$826,063 · 2
Top collaborators
- Vern L. Schramm5 shared
- Peter Tyler5 shared
Most similar at Texas A&M Agrilife Research
Same institution · by research overlap
- Peter Tyler$1,718,251
Others in their field
Other Emerging Leaders on “Trypanosoma Cruzi”
- Richard Grant · University Of Washington$3,353,469
- Erik Debler · Thomas Jefferson University$3,254,531
- Claudia P Herrera · Tulane University Of Louisiana$2,616,759
- Faustino Torrico · University Of Texas El Paso$2,573,277
- Joaquim Gascon · University Of Texas El Paso$2,573,277
- Laura-Isobel McCall · University Of Oklahoma$2,492,041
Research focus
Trypanosoma CruziCellsToxic EffectAnimal ModelPharmaceutical PreparationsCentral AmericaMalariaMedicalVaccinesChagas DiseaseSouth AmericaTherapeutic AgentsInfectionHuman DiseaseActive SitesEnzymesStructureReportingProteinsDrug KineticsParasitesNanomolarEnzyme Inhibitor DrugsNovel Therapeutics
Grant awards (9)
SELF-MASKED ALDEHYDES AS INHIBITORS OF THE CYSTEINE PROTEASES 3CL PROTEASE, CATHEPSIN L, AND CRUZAIN$196,856
R21 · FY2023 · AI · contact PI
SELF-MASKED ALDEHYDES AS INHIBITORS OF THE CYSTEINE PROTEASES 3CL PROTEASE, CATHEPSIN L, AND CRUZAIN$233,247
R21 · FY2022 · AI · contact PI
PROTOZOAN PURINE PHOSPHORIBOSYLTRANSFERASES AS TARGETS TO TREAT MALARIA, AFRICAN TRYPANOSOMIASIS AND CHAGAS'S DISEASE$1,003,662
R01 · FY2021 · AI · contact PI
PROTOZOAN PURINE PHOSPHORIBOSYLTRANSFERASES AS TARGETS TO TREAT MALARIA, AFRICAN TRYPANOSOMIASIS AND CHAGAS'S DISEASE$1,020,767
R01 · FY2020 · AI · contact PI
PROTOZOAN PURINE PHOSPHORIBOSYLTRANSFERASES AS TARGETS TO TREAT MALARIA, AFRICAN TRYPANOSOMIASIS AND CHAGAS'S DISEASE$1,014,009
R01 · FY2019 · AI · contact PI
PROTOZOAN PURINE PHOSPHORIBOSYLTRANSFERASES AS TARGETS TO TREAT MALARIA, AFRICAN TRYPANOSOMIASIS AND CHAGAS'S DISEASE$1,032,586
R01 · FY2018 · AI · contact PI
Novel Inhibitors of Cruzain and Trypanosoma brucei Cathpesin B as Potential Drug Candidates for the Treatment of African Trypanosomiasis and Chagas Disease$189,280
R21 · FY2018 · AI · contact PI
PROTOZOAN PURINE PHOSPHORIBOSYLTRANSFERASES AS TARGETS TO TREAT MALARIA, AFRICAN TRYPANOSOMIASIS AND CHAGAS'S DISEASE$1,083,730
R01 · FY2017 · AI · contact PI
Novel Inhibitors of Cruzain and Trypanosoma brucei Cathpesin B as Potential Drug Candidates for the Treatment of African Trypanosomiasis and Chagas Disease$206,680
R21 · FY2017 · AI · contact PI